---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-074256"
form_type: "8-K"
ticker: "HSDT"
cik: "0001610853"
company_name: "Solana Co"
filed_at: "2023-06-23T23:59:59+00:00"
generated_at: "2026-06-13T18:06:14.054897+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Helius Medical enters $1.95M ATM equity offering with Roth Capital

## Summary
- Company signed Sales Agreement with Roth Capital to sell up to $1.95M of Class A common stock at market prices.
- Roth Capital will receive 3.0% commission on gross proceeds from any sales under the at-the-market offering.
- Offerings will be made under an existing S-3 registration statement effective May 26, 2023.
- Company is not obligated to sell any shares; either party may suspend or terminate the offering.
- Net proceeds are expected to be used for general corporate purposes.

## SEC filing metadata
- accession: 0001104659-23-074256
- form_type: 8-K
- ticker: HSDT
- cik: 0001610853
- company_name: Solana Co
- filed_at: 2023-06-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1610853/000110465923074256/0001104659-23-074256-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1610853/000110465923074256/tm2319490d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-074256
- JSON: https://secwatch.observer/filing/0001104659-23-074256.json
- Plain text: https://secwatch.observer/filing/0001104659-23-074256.txt

## Key facts
- Material Agreements
  Solana Co entered into Sales Agreement with Roth Capital Partners, LLC valued at up to $1.95 million (effective 2023-06-23).
  - Action: entry
  - Agreement: atm program
  - Counterparty: Roth Capital Partners, LLC
  - Value: up to $1.95 million
  - Effective: 2023-06-23
  source text: On June 23, 2023, Helius Medical Technologies, Inc. (the “Company”) entered into a Sales Agreement (the “Sales Agreement”) with Roth Capital Partners, LLC, as agent (the “Sales Agent”). Pursuant to the Sales Agreement, the Company may offer and sell up to $1.95 million in shares of Class A common stock, par value $0.001 per share (the “Shares”), from time to time through the Sales Agent.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1610853/000110465923074256/0001104659-23-074256-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.